88 results
8-K
EX-99.1
ADAP
Adaptimmune Therapeutics Plc
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
Exhibit 99.1
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
- Organizational changes strengthen … , and additional changes to its R&D organization.
“Elliot has done a fantastic job as acting CMO over the past few months. This builds on his impact
6-K
EX-99.1
ADAP
Adaptimmune Therapeutics Plc
9 Oct 15
Adaptimmune announces New Research and Development Facility in Oxfordshire
12:00am
will provide best-in-class laboratories to support the expansion of our R&D team and enable continuing progress with our research programs,” said James … for Adaptimmune’s new R&D building, Oxfordshire.
L-R: Adrian Rawcliffe (CFO, Adaptimmune) - Philip Campbell (Commercial Director, MEPC) - Dr Helen
8-K
EX-99.1
ADAP
Adaptimmune Therapeutics Plc
1 Aug 19
Adaptimmune Reports Second Quarter 2019 Financial Results and Business Update
7:23am
Patient Supply Officer -
- Rafael Amado, President of R&D, leaving the Company -
- Initiated collaboration with Alpine Immune Sciences to develop next … of R&D, will leave the Company on August 12, 2019
· The new Executive Team will comprise Adrian Rawcliffe (Chief Executive Officer), Bill Bertrand
8-K
EX-99.1
ADAP
Adaptimmune Therapeutics Plc
27 Jun 19
Departure of Directors or Certain Officers
8:08am
Avidex, I am proud to have built technologies, teams and partnerships to create strong R&D platforms and a rich pipeline. Now that the Company … Worldwide Business Development and R&D Finance, where he was responsible for all business development and finance activities for GSK’s
8-K
EX-99.1
rbthsw9wk1cg7
27 Feb 19
Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
7:43am
8-K
EX-99.1
0brkj
6 May 21
Adaptimmune Reports First Quarter Financial Results and Business Update
7:38am
8-K
EX-99.1
3si5kmb4r63go
2 Aug 18
Adaptimmune Reports Second Quarter 2018 Financial Results and Business Update
7:41am
8-K
EX-99.1
xiv1sv l9s
5 Nov 20
Adaptimmune Reports Q3 Financial Results and Business Update
7:40am
8-K
EX-99.1
w5zq 5fn043
4 Aug 22
Adaptimmune Reports Second-Quarter Financial Results and Business Update
7:36am
8-K
EX-99.1
9t6x4 fbstfg6cgb
9 Aug 21
Adaptimmune Reports Second Quarter Financial Results and Business Update
4:08pm
8-K
EX-99.1
f3c5eq pkl
27 Feb 20
Adaptimmune Reports Fourth Quarter / Full Year 2019 Financial Results and Business Update
7:39am
8-K
EX-99.1
wcwhpvt
6 Nov 19
Adaptimmune Reports Third Quarter 2019 Financial Results and Business Update
7:35am
8-K
EX-99.1
4w2dayc5e53n24mc15c9
4 Nov 21
Adaptimmune Reports Third Quarter Financial Results and Business Update
7:40am
8-K
EX-99.1
66cbc2l2
6 May 19
Adaptimmune Reports First Quarter 2019 Financial Results
7:38am
8-K
EX-99.1
0t9z w6nu
6 Nov 18
Adaptimmune Reports Third Quarter 2018 Financial Results and Business Update
7:36am
8-K
EX-99.1
d4adn65hc7
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am
8-K
EX-99.1
k5g 7ezhn2
6 Mar 24
Adaptimmune Reports Q4 /Full Year 2023 Financial Results and Business Updates
7:05am
8-K
EX-99.1
tofk4ewdt927
9 May 22
Adaptimmune Reports First Quarter Financial Results and Business Update
7:40am
8-K/A
EX-99.1
7vu2as sz2
27 Feb 19
CORRECTING and REPLACING — Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
5:16pm